Have questions? Visit https://www.reddit.com/r/SNPedia

rs2631372

From SNPedia

Orientationminus
Stabilizedplus
Make rs2631372(C;C)
Make rs2631372(C;G)
Make rs2631372(G;G)
ReferenceGRCh38 38.1/142
Chromosome5
Position132367886
GeneMIR4750
is asnp
is mentioned by
dbSNPrs2631372
ebirs2631372
HLIrs2631372
Exacrs2631372
Varsomers2631372
Maprs2631372
PheGenIrs2631372
hapmaprs2631372
1000 genomesrs2631372
hgdprs2631372
ensemblrs2631372
gopubmedrs2631372
geneviewrs2631372
scholarrs2631372
googlers2631372
pharmgkbrs2631372
gwascentralrs2631372
openSNPrs2631372
23andMers2631372
23andMe allrs2631372
SNP Nexus

SNPshotrs2631372
SNPdbers2631372
MSV3drs2631372
GWAS Ctlgrs2631372
GMAF0.2856
Max Magnitude
? (C;C) (C;G) (G;G) 28
Rs2631372
PubMed [PMID 17684544OA-icon.png]
Affy Probeset SNP_A-1983493
Affy Orientation reverse
On GW 5.0 1
Alleles A/B C/G
Ancestral C
Population EU(German)
Allele C
Case Freq. 0.72
Control Freq. 0.69
Odds Ratio Het
Odds Ratio Hom
Odds Ratio All 1.28
Disease Crohn's disease (CD)


rs2631372 increases susceptibility to Crohn's disease 1.28 times for carriers of the C allele [PMID 17684544OA-icon.png]


[PMID 21695374] Haplotype in the IBD5 region is associated with refractory Crohn's disease in Slovenian patients and modulates expression of the SLC22A5 gene


[PMID 23127916] Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy